StonvexLoading…
StonvexStonvexStonvexCore line items from DVN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.51B | $16.79B | $12.85B | $8.60B |
Operating Income | $166.00M | $3.47B | $2.72B | $1.81B |
Net Income | $120.00M | $2.64B | $2.08B | $1.39B |
EPS (Diluted) | $0.19 | $4.17 | $3.27 | $2.17 |
Total Assets | $32.54B | $31.60B | $31.22B | $31.39B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.76B | $1.38B | $1.23B | $1.71B |
Free Cash Flow OCF − CapEx | $816.00M | $3.12B | $2.42B | $1.60B |
Shares Outstanding | 618.00M | 633.00M | 637.00M | 641.00M |